共 50 条
Pulmonary artery compliance in different forms of pulmonary hypertension
被引:10
|作者:
McCormick, Amber
[1
]
Krishnan, Amita
[1
]
Badesch, David
[2
]
Benza, Raymond L.
[3
]
Bull, Todd M.
[2
]
De Marco, Teresa
[4
]
Feldman, Jeremy
[5
]
Hemnes, Anna R.
[6
]
Hirsch, Russel
[7
]
Horn, Evelyn
[8
]
Kennedy, Jaime
[9
]
Mathai, Stephen C.
[10
]
McConnell, Wesley
[11
]
Pugliese, Steven C.
[12
]
Sager, Jeffrey S.
[13
]
Shlobin, Oksana A.
[14
]
Simon, Marc A.
[4
]
Lammi, Matthew R.
[1
]
机构:
[1] Louisiana State Univ, Comprehens Pulm Hypertens Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA
[2] Univ Colorado Anschutz Med Campus, Div Pulm Sci & Crit Care Med, Denver, CO USA
[3] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Cardiovasc Med, Columbus, OH USA
[4] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA
[5] Arizona Pulm Specialists, Phoenix, AZ USA
[6] Vanderbilt Univ, Allergy Pulm & Crit Care Med, Nashville, TN USA
[7] Cincinnati Childrens Hosp Med Ctr, Heart Inst, Cincinnati, OH USA
[8] Weill Cornell Med Coll, Div Cardiol, New York, NY USA
[9] Inova Heart & Vasc Inst, Falls Church, VA USA
[10] Johns Hopkins Univ, Pulm & Crit Care Med, Baltimore, MD USA
[11] Kentuckiana Pulm Associates, Louisville, KY USA
[12] Univ Penn, Pulm Allergy & Crit Care, Philadelphia, PA USA
[13] Cottage Pulm Hypertens Ctr, Santa Barbara, CA USA
[14] Inova Fairfax Hosp, Adv Lung Disesae & Transplant Program, Falls Church, VA USA
来源:
关键词:
Pulmonary Arterial Hypertension;
Pulmonary Embolism;
RIGHT-VENTRICULAR AFTERLOAD;
SYSTEMIC-SCLEROSIS;
VASCULAR-RESISTANCE;
TIME CONSTANT;
CAPACITANCE;
MANAGEMENT;
SURVIVAL;
THERAPY;
D O I:
10.1136/heartjnl-2022-321760
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Objective Pulmonary artery compliance (PAC), estimated as stroke volume (SV) divided by pulmonary artery pulse pressure (PP), may be a predictor of survival in pulmonary arterial hypertension (PAH). Resistance- compliance (RC) time, the product of PAC and pulmonary vascular resistance, is reported to be a physiological constant. We investigated if differences in PAC and RC time exist between pulmonary hypertension (PH) subgroups and examined whether PAC is an independent predictor of transplant- free survival in PAH.Methods This was a retrospective analysis of adult PAH (n=532) and chronic thromboembolic PH (CTEPH, n=84) patients enrolled in the US Pulmonary Hypertension Association Registry from 2015 to 2019. PAC and RC time were compared between PH subgroups (connective tissue disease-PAH (CTD-PAH), idiopathic/heritable-PAH (i/h- PAH), drug/toxin- PAH (d/t-PAH)). Cox proportional hazards models were constructed for transplant- free survival, adjusting for REVEAL 2.0 risk score.Results There were no differences in estimated PAC between PAH subgroups, nor between PAH and CTEPH. RC time was shorter in CTEPH compared with PAH (median 0.55 (IQR 0.45-0.64) vs 0.62 (0.52-0.73) s, p < 0.0001). RC time was shortest in CTD- PAH when compared with i/h- PAH and d/t- PAH ((0.59 +/- 0.18) vs (0.65 +/- 0.20) vs (0.73 +/- 0.25) s, p=0.0001). PAC was associated with transplant- free survival (HR 0.72, 95% CI 0.55 to 0.94, p=0.02) but was not an independent predictor of outcome after adjustment for REVEAL 2.0 score.Conclusion PAC was similar between PH groups and was not an independent predictor of transplant- free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy.
引用
收藏
页码:1098 / 1105
页数:8
相关论文